Jounce Therapeutics, Inc. Stock
Equities
JNCE
US4811161011
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Michael Hearne
DFI | Director of Finance/CFO | - | - |
Eric Laub
IRC | Investor Relations Contact | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 18 M€ | +2.79% | - |
1st Jan change | Capi. | |
---|---|---|
-3.10% | 102B | |
+2.11% | 96.37B | |
-1.80% | 21.37B | |
-17.75% | 20.92B | |
-6.91% | 18.64B | |
-42.00% | 16.4B | |
-28.19% | 13.53B | |
+0.18% | 13.28B | |
+19.90% | 10.85B |